• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1,140
109
75
71
68

COUNTRY

70
22
16
10
9

CATEGORIES

  • 574
  • 120
  • 550
  • 75
  • 526
  • 43
  • 505
  • 18
  • 18
  • 23

PRICE

1,036
1,235
1,968
2,993

PUBLISHED

21
204
653
2,993

PRODUCT TYPE

2,420
494
69
7
1
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE
Cervical Cancer - Pipeline Review, H1 2013 Cervical Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Cervical Cancer - Pipeline Review, H1 2013

Cervical Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cervical Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM
Anaplastic Thyroid Cancer - Pipeline Review, H1 2013 Anaplastic Thyroid Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Anaplastic Thyroid Cancer - Pipeline Review, H1 2013

Anaplastic Thyroid Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Anaplastic Thyroid Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM
Malignant Pleural Mesothelioma - Pipeline Review, H1 2013 Malignant Pleural Mesothelioma - Pipeline Review, H1 2013 - Product Thumbnail Image

Malignant Pleural Mesothelioma - Pipeline Review, H1 2013

Global Markets Direct's, 'Malignant Pleural Mesothelioma - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic...

February 2013
FROM
Small-Cell Lung Cancer - Pipeline Review, H1 2013 Small-Cell Lung Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Small-Cell Lung Cancer - Pipeline Review, H1 2013

Small-Cell Lung Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Small-Cell Lung Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM
Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2013 Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2013 - Product Thumbnail Image

Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2013

Gastrointestinal Stromal Tumor (GIST) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2013', provides an overview of the indication’s...

February 2013
FROM
Medulloblastoma - Pipeline Review, H1 2013 Medulloblastoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Medulloblastoma - Pipeline Review, H1 2013

Medulloblastoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Medulloblastoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2013 Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2013 - Product Thumbnail Image

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2013

Global Markets Direct's, 'Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report...

February 2013
FROM
Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013 Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013 - Product Thumbnail Image

Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013

Global Markets Direct's, 'Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on...

February 2013
FROM
Malignant Neoplasms - Pipeline Review, H1 2013 Malignant Neoplasms - Pipeline Review, H1 2013 - Product Thumbnail Image

Malignant Neoplasms - Pipeline Review, H1 2013

Malignant Neoplasms – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Malignant Neoplasms - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

February 2013
FROM
Peritoneal Cancer - Pipeline Review, H1 2013 Peritoneal Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Peritoneal Cancer - Pipeline Review, H1 2013

Peritoneal Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Peritoneal Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM
Metastatic Colorectal Cancer - Pipeline Review, H1 2013 Metastatic Colorectal Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Colorectal Cancer - Pipeline Review, H1 2013

Metastatic Colorectal Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Colorectal Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

February 2013
FROM
Metastatic Pancreatic Cancer - Pipeline Review, H1 2013 Metastatic Pancreatic Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Pancreatic Cancer - Pipeline Review, H1 2013

Metastatic Pancreatic Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Pancreatic Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

February 2013
FROM
Colon Cancer - Pipeline Review, H1 2013 Colon Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Colon Cancer - Pipeline Review, H1 2013

Colon Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Colon Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM
Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2013 Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2013

Metastatic Renal Cell Carcinoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

February 2013
FROM
Malignant Mesothelioma - Pipeline Review, H1 2013 Malignant Mesothelioma - Pipeline Review, H1 2013 - Product Thumbnail Image

Malignant Mesothelioma - Pipeline Review, H1 2013

Malignant Mesothelioma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Malignant Mesothelioma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM
Myelodysplastic Syndrome - Pipeline Review, H1 2013 Myelodysplastic Syndrome - Pipeline Review, H1 2013 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Review, H1 2013

Myelodysplastic Syndrome – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Myelodysplastic Syndrome - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM
Oral Mucositis - Pipeline Review, H1 2013 Oral Mucositis - Pipeline Review, H1 2013 - Product Thumbnail Image

Oral Mucositis - Pipeline Review, H1 2013

Oral Mucositis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Oral Mucositis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM
Melanoma - Pipeline Review, H1 2013 Melanoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Melanoma - Pipeline Review, H1 2013

Melanoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

February 2013
FROM
Endometrial Cancer - Pipeline Review, H1 2013 Endometrial Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Endometrial Cancer - Pipeline Review, H1 2013

Endometrial Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Endometrial Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

February 2013
FROM
Ewing Sarcoma - Pipeline Review, H1 2013 Ewing Sarcoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Ewing Sarcoma - Pipeline Review, H1 2013

Ewing Sarcoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ewing Sarcoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM
Loading Indicator

Our Clients

Our clients' logos